In the BioHarmony Drug Report Database

"Preview" Icon

Dorzolamide

Trusopt (dorzolamide) is a small molecule pharmaceutical. Dorzolamide was first approved as Trusopt on 1994-12-09. It is used to treat open-angle glaucoma in the USA. It is known to target carbonic anhydrase 7, carbonic anhydrase 12, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 4.

 

Trade Name

 

Trusopt
 

Common Name

 

dorzolamide
 

ChEMBL ID

 

CHEMBL218490
 

Indication

 

open-angle glaucoma
 

Drug Class

 

Carbonic anhydrase inhibitors

Image (chem structure or protein)

Dorzolamide structure rendering